Clinical trials can test effectiveness
Your feature on the introduction of the Alzheimer's drug, donepezil, in the Withington Hospital, Manchester, ('Making introductions', pages 28-29, 25 February) stated that 'evidence of its efficacy in clinical use and its cost-effectiveness can only be obtained from further research and audit after its introduction in clinical practice'.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here